NIHR Bristol Cardiovascular Biomedical Research Unit, Cardiac Magnetic Resonance Department, Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Upper Maudlin Street, Bristol BS2 8HW, UK
School of Physiology, Pharmacology and Neuroscience, Biomedical Sciences, University of Bristol, BS8 2TD, UK.
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1405-1413. doi: 10.1093/ehjci/jev329. Epub 2015 Dec 24.
We sought to determine the prevalence of asymmetric hypertensive heart disease (HHD) overlapping morphologically with hypertrophic cardiomyopathy (HCM) and to determine predictors of this pattern of hypertensive remodelling.
One hundred and fifty hypertensive patients underwent 1.5 T cardiovascular magnetic resonance imaging. Twenty-one patients were excluded due to concomitant cardiac pathology that may confound the hypertrophic response, e.g. myocardial infarction, moderate-severe valvular disease, or other cardiomyopathy. Asymmetric HHD was defined as a segmental wall thickness of ≥15 mm and >1.5-fold the opposing wall in ≥1 myocardial segments, measured from short-axis cine stack at end-diastole. Ambulatory blood pressure, myocardial replacement fibrosis, aortic distensibility and aortoseptal angle were investigated as predictors of asymmetric HHD by multivariate logistic regression. Out of 129 hypertensive subjects (age: 51 ± 15 years, 50% male, systolic blood pressure: 170 ± 30 mmHg, diastolic blood pressure: 97 ± 16 mmHg), asymmetric HHD occurred in 21%. Where present, maximal end-diastolic wall thickness (EDWT) was 17.8 ± 1.9 mm and located exclusively in the basal or mid septum. In asymmetric HHD, aortoseptal angle (114 ± 10° vs. 125 ± 9° vs. 123 ± 12°, P < 0.05, respectively) was significantly reduced compared to concentric left ventricular hypertrophy (LVH) and compared to no LVH, respectively. Aortic distensibility in asymmetric HHD (1.01 ± 0.60 vs. 1.83 ± 1.65 mm/mmHg × 10, P < 0.05, respectively) was significantly reduced compared to subjects with no LVH. Age (odds ratio [95th confidence interval]: 1.10 [1.02-1.18], P < 0.05) and indexed LV mass (1.09 [0.98-1.28], P < 0.0001) were significant, independent predictors of asymmetric HDD.
Asymmetric HHD morphologically overlapping with HCM, according to the current ESC guidelines, is common. Postulating a diagnosis of HCM on the basis of EDWT of ≥15 mm should be made with caution in the presence of arterial hypertension particular in male subjects with elevated LV mass.
我们旨在确定与肥厚型心肌病(HCM)形态上重叠的不对称性高血压性心脏病(HHD)的患病率,并确定这种高血压重塑模式的预测因素。
150 例高血压患者接受了 1.5 T 心血管磁共振成像检查。由于可能使肥厚反应复杂化的合并性心脏病理学,例如心肌梗死、中重度瓣膜病或其他心肌病,有 21 例患者被排除在外。不对称性 HHD 的定义为在舒张末期短轴电影堆栈中,≥1 个心肌节段的节段性壁厚度≥15mm,且比对侧壁厚≥1.5 倍。通过多变量逻辑回归研究动态血压、心肌替代纤维化、主动脉顺应性和主动脉室间隔角作为不对称 HHD 的预测因素。在 129 例高血压患者(年龄:51±15 岁,50%为男性,收缩压:170±30mmHg,舒张压:97±16mmHg)中,21 例存在不对称性 HHD。存在时,最大舒张末期壁厚度(EDWT)为 17.8±1.9mm,仅位于基底或中部室间隔。在不对称性 HHD 中,主动脉室间隔角(114±10°比 125±9°比 123±12°,P<0.05)与同心性左心室肥厚(LVH)相比明显降低,与无 LVH 相比也明显降低。不对称性 HHD 的主动脉顺应性(1.01±0.60比 1.83±1.65mm/mmHg×10,P<0.05)明显低于无 LVH 的患者。年龄(比值比[95%置信区间]:1.10[1.02-1.18],P<0.05)和指数化 LV 质量(1.09[0.98-1.28],P<0.0001)是不对称性 HDD 的显著、独立预测因素。
根据当前 ESC 指南,与 HCM 形态上重叠的不对称性 HHD 很常见。在存在高血压的情况下,特别是在 LV 质量升高的男性患者中,基于 EDWT≥15mm 做出 HCM 的诊断应该谨慎。